| Scientific Name |
Dolutegravir, Abacavir, Lamivudine
|
|---|---|
| Brand Name |
Triumeq
|
| Risk |
Neural tube defects reported in infants born to women exposed to dolutegravir at the time of conception, in Tsepamo Study, Botswana.
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|